Alliance Pharma Share News (APH)

IN BRIEF: Alliance Pharma drops as CEO departs, delays results again

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Shares close down 14% in London on Wednesday, after Alliance Pharma says Chief Executive Officer Peter Butterfield has decided to leave the company "to pursue other business interests". Following a "comprehensive" search process, it appoints Nick Sedgwick as new CEO, starting on Monday next week. Sedgwick has 30 years experience in consumer health, Alliance Pharma says, most recently as regional director for UK & Ireland Consumer Health at Reckitt Benckiser Group PLC. Butterfield will remain with Alliance Pharma until June 30 to facilitate a "thorough" handover, it says. Butterfield joined the board in 2010 and became CEO in 2018.

Butterfield out, Sedgwick in as Alliance Pharma CEO

(Sharecast News) - Alliance Pharma announced a significant leadership transition on Wednesday, with chief executive Peter Butterfield stepping down from his role to pursue other business interests.

AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

UK earnings, trading statements calendar - next 7 days

EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News:

Alliance Pharma delays preliminary results

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.

UK earnings, trading statements calendar - next 7 days

Alliance Pharma to delay release of 2023 results

(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Alliance Pharma names Camillo Pane as chair

(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth through marketing and innovation.

RBC Capital Markets nudges down Alliance Pharma price target

(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its forecasts as trading normalises.

LONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts Victrex

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Alliance Pharma reports annual boost in revenue; eyes flat 2024 profit

(Alliance News) - Alliance Pharma PLC on Monday said second-half recovery drove its full-year "record" revenue but noted that it does not expect profit growth in 2024.